Literature DB >> 11238909

Phosphorylation and rapid relocalization of 53BP1 to nuclear foci upon DNA damage.

L Anderson1, C Henderson, Y Adachi.   

Abstract

53BP1 is a human BRCT protein that was originally identified as a p53-interacting protein by the Saccharomyces cerevisiae two-hybrid screen. Although the carboxyl-terminal BRCT domain shows similarity to Crb2, a DNA damage checkpoint protein in fission yeast, there is no evidence so far that implicates 53BP1 in the checkpoint. We have identified a Xenopus homologue of 53BP1 (XL53BP1). XL53BP1 is associated with chromatin and, in some cells, localized to a few large foci under normal conditions. Gamma-ray irradiation induces increased numbers of the nuclear foci in a dose-dependent manner. The damage-induced 53BP1 foci appear rapidly (in 30 min) after irradiation, and de novo protein synthesis is not required for this response. In human cells, 53BP1 foci colocalize with Mrel1 foci at later stages of the postirradiation period. XL53BP1 is hyperphosphorylated after X-ray irradiation, and inhibitors of ATM-related kinases delay the relocalization and reduce the phosphorylation of XL53BP1 in response to X-irradiation. In AT cells, which lack ATM kinase, the irradiation-induced responses of 53BP1 are similarly affected. These results suggest a role for 53BP1 in the DNA damage response and/or checkpoint control which may involve signaling of damage to p53.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11238909      PMCID: PMC86718          DOI: 10.1128/MCB.21.5.1719-1729.2001

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  67 in total

Review 1.  Checkpoints: controls that ensure the order of cell cycle events.

Authors:  L H Hartwell; T A Weinert
Journal:  Science       Date:  1989-11-03       Impact factor: 47.728

2.  RuvAB acts at arrested replication forks.

Authors:  M Seigneur; V Bidnenko; S D Ehrlich; B Michel
Journal:  Cell       Date:  1998-10-30       Impact factor: 41.582

3.  Caffeine-induced uncoupling of mitosis from the completion of DNA replication in mammalian cells.

Authors:  R Schlegel; A B Pardee
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

4.  Efficiency of poly(A).poly(U) as an adjuvant.

Authors:  A G Hovanessian; J Galabru; Y Rivière; L Montagnier
Journal:  Immunol Today       Date:  1988-06

Review 5.  Cell cycle control and cancer.

Authors:  L H Hartwell; M B Kastan
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

6.  The BRCT domain of the S. cerevisiae checkpoint protein Rad9 mediates a Rad9-Rad9 interaction after DNA damage.

Authors:  J Soulier; N F Lowndes
Journal:  Curr Biol       Date:  1999-05-20       Impact factor: 10.834

7.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase.

Authors:  S Matsuoka; M Huang; S J Elledge
Journal:  Science       Date:  1998-12-04       Impact factor: 47.728

8.  Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes.

Authors:  T Haaf; E I Golub; G Reddy; C M Radding; D C Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-14       Impact factor: 11.205

9.  Two cellular proteins that bind to wild-type but not mutant p53.

Authors:  K Iwabuchi; P L Bartel; B Li; R Marraccino; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  Radiation-induced DNA double-strand break rejoining in human tumour cells.

Authors:  M I Núñez; M Villalobos; N Olea; M T Valenzuela; V Pedraza; T J McMillan; J M Ruiz de Almodóvar
Journal:  Br J Cancer       Date:  1995-02       Impact factor: 7.640

View more
  148 in total

1.  PA200, a nuclear proteasome activator involved in DNA repair.

Authors:  Vicença Ustrell; Laura Hoffman; Gregory Pratt; Martin Rechsteiner
Journal:  EMBO J       Date:  2002-07-01       Impact factor: 11.598

2.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Double-strand break motions shift radiation risk notions?

Authors:  Lynn Hlatky
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-30       Impact factor: 11.205

4.  TopBP1 functions with 53BP1 in the G1 DNA damage checkpoint.

Authors:  Rachele Cescutti; Simona Negrini; Masaoki Kohzaki; Thanos D Halazonetis
Journal:  EMBO J       Date:  2010-09-24       Impact factor: 11.598

5.  Expression of DNA damage checkpoint 53BP1 is correlated with prognosis, cell proliferation and apoptosis in colorectal cancer.

Authors:  Jianping Bi; Ai Huang; Tao Liu; Tao Zhang; Hong Ma
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

Review 6.  Double-strand break repair: 53BP1 comes into focus.

Authors:  Stephanie Panier; Simon J Boulton
Journal:  Nat Rev Mol Cell Biol       Date:  2013-12-11       Impact factor: 94.444

7.  p53 Binding protein 53BP1 is required for DNA damage responses and tumor suppression in mice.

Authors:  Irene M Ward; Kay Minn; Jan van Deursen; Junjie Chen
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

8.  Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation.

Authors:  Erik S Zimmerman; Junjie Chen; Joshua L Andersen; Orly Ardon; Jason L Dehart; Jana Blackett; Shailesh K Choudhary; David Camerini; Paul Nghiem; Vicente Planelles
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  Peripheral subnuclear positioning suppresses Tcrb recombination and segregates Tcrb alleles from RAG2.

Authors:  Elizabeth A W Chan; Grace Teng; Elizabeth Corbett; Kingshuk Roy Choudhury; Craig H Bassing; David G Schatz; Michael S Krangel
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

Review 10.  53BP1: pro choice in DNA repair.

Authors:  Michal Zimmermann; Titia de Lange
Journal:  Trends Cell Biol       Date:  2013-10-04       Impact factor: 20.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.